(Q34636623)

3 August 2017

1 reference

title

Vaccines against genital herpes: progress and limitations (English)

1 reference

3 August 2017

1 reference

Lynda A Morrison

1

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

62

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

1119-1129

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200262080-00001

3 August 2017

exact match

0 references

cites work

HLA-DQ tetramers identify epitope-specific T cells in peripheral blood of herpes simplex virus type 2-infected individuals: direct detection of immunodominant antigen-responsive cells

1 reference

12 December 2020

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

1 reference

12 December 2020

DNA immunization against experimental genital herpes simplex virus infection

1 reference

12 December 2020

Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands

1 reference

12 December 2020

Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules

1 reference

12 December 2020

Persistence of virus shedding in asymptomatic women after recovery from herpes genitalis

1 reference

12 December 2020

Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes

1 reference

12 December 2020

Perinatal risk associated with maternal genital herpes simplex virus infection

1 reference

12 December 2020

Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs

1 reference

12 December 2020

Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2

1 reference

12 December 2020

Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine

1 reference

12 December 2020

Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals

1 reference

12 December 2020

Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

12 December 2020

Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection

1 reference

12 December 2020

Herpes simplex virus-2 infection. An emerging disease?

1 reference

12 December 2020

Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections

1 reference

12 December 2020

Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease

1 reference

12 December 2020

Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines

1 reference

12 December 2020

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group

1 reference

12 December 2020

Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial

1 reference

12 December 2020

Neonatal herpes simplex virus infection in the British Isles

1 reference

12 December 2020

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

1 reference

12 December 2020

Immune protection against HSV-2 in B-cell-deficient mice

1 reference

12 December 2020

Genital herpes vaccine shows limited promise

1 reference

12 December 2020

A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]

1 reference

12 December 2020

Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells

1 reference

12 December 2020

Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in mice

1 reference

12 December 2020

Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.

1 reference

12 December 2020

Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type

1 reference

12 December 2020

Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection

1 reference

12 December 2020

Herpes simplex virus type 2 in the United States, 1976 to 1994.

1 reference

12 December 2020

The efficacy and safety of Skinner herpes simplex vaccine towards modulation of herpes genitalis; report of a prospective double-blind placebo-controlled trial

1 reference

12 December 2020

Protection by minigenes: a novel approach of DNA vaccines

1 reference

12 December 2020

Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines

1 reference

12 December 2020

Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes

1 reference

12 December 2020

T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.

1 reference

12 December 2020

Protective immune correlates can segregate by vaccine type in a murine herpes model system.

1 reference

12 December 2020

Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection.

1 reference

12 December 2020

Neonatal herpes policy in The Netherlands. Five years after a consensus conference

1 reference

12 December 2020

Herpes simplex virus turns off the TAP to evade host immunity

1 reference

12 December 2020

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes

1 reference

12 December 2020

Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe

1 reference

12 December 2020

Clinical studies with herpes simplex virus type 2 Curtis strain vaccine

1 reference

12 December 2020

Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: characterization of the immunoglobulins in vaginal mucus

1 reference

12 December 2020

Evolution of recurrent herpes simplex lesions. An immunohistologic study

1 reference

12 December 2020

Inhibition of dendritic cell maturation by herpes simplex virus

1 reference

12 December 2020

Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis

1 reference

12 December 2020

CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins

1 reference

12 December 2020

Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population.

1 reference

12 December 2020

Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models.

1 reference

12 December 2020

Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain.

1 reference

12 December 2020

Recurrent genital herpes among women: symptomatic v. asymptomatic viral shedding

1 reference

12 December 2020

A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection

1 reference

12 December 2020

Adenovirus vectors as potential vaccines against herpes simplex virus.

1 reference

12 December 2020

Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems

1 reference

12 December 2020

IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge

1 reference

12 December 2020

Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine

1 reference

12 December 2020

Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice

1 reference

12 December 2020

The natural history of herpes simplex virus infection of mother and newborn

1 reference

12 December 2020

Changing presentation of herpes simplex virus infection in neonates

1 reference

12 December 2020

Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells

1 reference

12 December 2020

Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection

1 reference

12 December 2020

Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules

1 reference

12 December 2020

Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations

1 reference

12 December 2020

The Association Between Genital Ulcer Disease and Acquisition of HIV Infection in Homosexual Men

1 reference

12 December 2020

Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization

1 reference

12 December 2020

DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo

1 reference

12 December 2020

Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract

1 reference

12 December 2020

Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions

1 reference

12 December 2020

Herpes simplex virus latency-associated transcript is a stable intron

1 reference

12 December 2020

Live vaccinia virus recombinants expressing herpes simplex virus genes

1 reference

12 December 2020

Tipping the scales of herpes simplex virus reactivation: the important responses are local

1 reference

12 December 2020

LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection

1 reference

12 December 2020

CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells.

1 reference

12 December 2020

DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model

1 reference

12 December 2020

Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth

1 reference

12 December 2020

Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein D plasmid constructs

1 reference

12 December 2020

Selecting and maintaining a diverse T-cell repertoire

1 reference

12 December 2020

Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled

1 reference

12 December 2020

DNA vaccines and immunity to herpes simplex virus

1 reference

12 December 2020

Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions

1 reference

12 December 2020

Secretory IgA Antibody in Cervicovaginal Secretions from Women with Genital Infection Due to Herpes Simplex Virus

1 reference

12 December 2020

A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease.

1 reference

12 December 2020

A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States

1 reference

12 December 2020

Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus

1 reference

12 December 2020

Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization

1 reference

12 December 2020

Surveillance report: disease trends at New Zealand sexually transmitted disease clinics 1977-1993

1 reference

12 December 2020

Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens

1 reference

12 December 2020

Risk Factors for the Sexual Transmission of Genital Herpes

1 reference

12 December 2020

Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.

1 reference

12 December 2020

10.2165/00003495-200262080-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1025163020

0 references

1 reference